Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution.
It has recently been shown that nucleosome distribution, histone modifications and RNA polymerase II (Pol II) occupancy show preferential association with exons ("exon-intron marking"), linking chromatin structure and function to co-transcriptional splicing in a variety of eukaryotes. Previous ChIP-sequencing studies suggested that these marking patterns reflect the nucleosomal landscape. By analyzing ChIP-chip datasets across the human genome in three cell types, we have found that this marking system is far more complex than previously observed. We show here that a range of histone modifications and Pol II are preferentially associated with exons. However, there is noticeable cell-type specificity in the degree of exon marking by histone modifications and, surprisingly, this is also reflected in some histone modifications patterns showing biases towards introns. Exon-intron marking is laid down in the absence of transcription on silent genes, with some marking biases changing or becoming reversed for genes expressed at different levels. Furthermore, the relationship of this marking system with splicing is not simple, with only some histone modifications reflecting exon usage/inclusion, while others mirror patterns of exon exclusion. By examining nucleosomal distributions in all three cell types, we demonstrate that these histone modification patterns cannot solely be accounted for by differences in nucleosome levels between exons and introns. In addition, because of inherent differences between ChIP-chip array and ChIP-sequencing approaches, these platforms report different nucleosome distribution patterns across the human genome. Our findings confound existing views and point to active cellular mechanisms which dynamically regulate histone modification levels and account for exon-intron marking. We believe that these histone modification patterns provide links between chromatin accessibility, Pol II movement and co-transcriptional splicing.
Dhami
Pawandeep
P
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
Saffrey
Peter
P
Bruce
Alexander W
AW
Dillon
Shane C
SC
Chiang
Kelly
K
Bonhoure
Nicolas
N
Koch
Christoph M
CM
Bye
Jackie
J
James
Keith
K
Foad
Nicola S
NS
Ellis
Peter
P
Watkins
Nicholas A
NA
Ouwehand
Willem H
WH
Langford
Cordelia
C
Andrews
Robert M
RM
Dunham
Ian
I
Vetrie
David
D
D005091:Exons / Q000235:genetics*; D005786:Gene Expression Regulation; D006657:Histones / Q000378:metabolism*; D006801:Humans; D007438:Introns / Q000235:genetics*; D020014:K562 Cells; D009707:Nucleosomes / Q000235:genetics* / Q000378:metabolism*; D012319:RNA Polymerase II / Q000378:metabolism; D014158:Transcription, Genetic
D006657:Histones; D009707:Nucleosomes; D012319:RNA Polymerase II
Mol Cell Biol. 2004 May;24(10):4092-103
15121832
Nat Genet. 2004 Aug;36(8):900-5
15247917
Cell. 2006 Apr 21;125(2):315-26
16630819
PLoS One. 2010 Feb 05;5(2):e9059
20140202
Cell Cycle. 2009 Oct 15;8(20):3420-4
19823040
J Biol Chem. 2002 Nov 8;277(45):43110-4
12221105
Nat Struct Mol Biol. 2009 Sep;16(9):996-1001
19684599
Cell. 2005 Nov 18;123(4):581-92
16286007
Biochem Soc Trans. 2006 Dec;34(Pt 6):1062-6
17073751
Genome Res. 2007 Jun;17(6):691-707
17567990
Nat Genet. 2008 Jul;40(7):897-903
18552846
Blood. 2009 May 7;113(19):e1-9
19228925
Genome Biol. 2009;10(3):R25
19261174
Science. 2001 Aug 10;293(5532):1074-80
11498575
Nature. 2007 Jun 14;447(7146):799-816
17571346
Mol Cell. 2009 Oct 23;36(2):245-54
19854133
EMBO J. 2010 May 19;29(10):1629-36
20407423
RNA. 2003 Aug;9(8):993-1006
12869710
J Immunol. 1980 Jul;125(1):6-12
7381211
J Biol Chem. 2005 May 6;280(18):17732-6
15760899
Science. 2010 Feb 19;327(5968):996-1000
20133523
Leuk Res. 1979;3(6):363-70
95026
Nat Struct Mol Biol. 2006 Jan;13(1):22-9
16341228
Nat Genet. 2005 Oct;37(10):1090-7
16155569
Mol Cell. 1999 May;3(5):593-600
10360175
Nat Struct Mol Biol. 2009 Sep;16(9):990-5
19684600
Genome Res. 2009 Oct;19(10):1732-41
19687145
J Biol Chem. 2004 Jul 9;279(28):29075-84
15126509
Cell. 2007 May 18;129(4):823-37
17512414
Genes Dev. 2004 Oct 15;18(20):2437-68
15489290
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6364-9
12750471
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4325-30
19251664
Genome Res. 2009 Jan;19(1):24-32
19056695
Genome Res. 2009 Jun;19(6):994-1005
19401398
Genes Dev. 2007 Jun 1;21(11):1422-30
17545470
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14494-9
11121052
Nat Genet. 2007 Mar;39(3):311-8
17277777
Nat Genet. 2009 Mar;41(3):376-81
19182803
Mol Cell. 2003 Aug;12(2):525-32
14536091
PLoS Genet. 2009 May;5(5):e1000470
19424417
Genome Res. 2007 Jun;17(6):877-85
17179217
J Neurochem. 2006 Sep;98(6):1828-40
16945103
Nature. 2003 Jan 23;421(6921):448-53
12540921
PLoS Comput Biol. 2009 Nov;5(11):e1000566
19918365
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14926-31
19706456
Cell. 2005 Nov 18;123(4):593-605
16286008
Nat Struct Mol Biol. 2009 Jul;16(7):717-24
19543290
Curr Opin Genet Dev. 2008 Apr;18(2):145-51
18372167
Mol Cell. 2007 Nov 30;28(4):665-76
18042460